Latest News about MRNA
Recent news which mentions MRNA
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
November 07, 2024
From Benzinga
From Benzinga
Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
November 07, 2024
From Benzinga
From Benzinga
Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr.
November 06, 2024
From Benzinga
From Motley Fool
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
November 06, 2024
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 05, 2024
From Benzinga
From Benzinga
In-Depth Examination Of 15 Analyst Recommendations For Moderna
November 04, 2024
Tickers
MRNA
From Benzinga
2 Dividend Stocks to Buy for a Lifetime of Passive Income
November 02, 2024
From Motley Fool
These 10 Stocks Were S&P 500's Top Performers In Biden's First Year: Could The Trend Continue If Harris Wins 2024 Election?
October 31, 2024
From Benzinga
Why Is Moderna Stock Trading Higher On Monday?
October 28, 2024
From Benzinga
How Bad Is This News for Novavax?
October 19, 2024
From Motley Fool
Benzinga Bulls And Bears: Apple, Tesla, Netflix, Oklo — And Dogecoin, Meme Coins Outpace Corporate Giants
October 19, 2024
From Benzinga
From Benzinga
Netflix, TSMC, American Express, Moderna, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 17, 2024
From Benzinga
From Benzinga
Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock
October 16, 2024
From Benzinga
Cathie Wood's Ark Offloads $1.28M In Jack Dorsey's Block Shares Despite Bitcoin Rally
October 15, 2024
From Benzinga
From Benzinga
GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement
October 15, 2024
From Benzinga
2 Biotech Stocks That Are Screaming Buys This Month
October 12, 2024
From Motley Fool
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
October 10, 2024
From Benzinga
Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer
October 10, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.